Acceleron Pharma Inc
CIK 1280600 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acceleron Pharma Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Dec 2, 2021 | 15-12B | 0001193125-21-346115 |
| Nov 24, 2021 | SC 13D/A | 0000902664-21-005099 |
| Nov 22, 2021 | 4 | 0001104659-21-142265 |
| Nov 22, 2021 | 4 | 0001104659-21-142271 |
| Nov 22, 2021 | SC TO-T/A | 0001193125-21-335885 |
| Nov 22, 2021 | 4 | 0001104659-21-142279 |
| Nov 22, 2021 | 4 | 0001104659-21-142280 |
| Nov 22, 2021 | 4 | 0001104659-21-142278 |
| Nov 22, 2021 | 4 | 0001104659-21-142269 |
| Nov 22, 2021 | 4 | 0001104659-21-142274 |
| Nov 22, 2021 | 8-K | 0001104659-21-142257 |
| Nov 22, 2021 | 4 | 0001104659-21-142277 |
| Nov 22, 2021 | 4 | 0001104659-21-142275 |
| Nov 22, 2021 | SC 14D9/A | 0001104659-21-142200 |
| Nov 22, 2021 | 25-NSE | 0001354457-21-001364 |
| Nov 22, 2021 | 4 | 0001104659-21-142272 |
| Nov 22, 2021 | 4 | 0001104659-21-142273 |
| Nov 22, 2021 | 4 | 0001104659-21-142266 |
| Nov 22, 2021 | 4 | 0001104659-21-142267 |
| Nov 17, 2021 | SC 14D9/A | 0000902664-21-005026 |
| Nov 17, 2021 | SC 14D9/A | 0001104659-21-140301 |
| Nov 17, 2021 | SC TO-T/A | 0001193125-21-331902 |
| Nov 12, 2021 | 4 | 0001179110-21-010095 |
| Nov 12, 2021 | SC 14D9/A | 0001104659-21-137430 |
| Nov 10, 2021 | SC 13G/A | 0000315066-21-001840 |